PMDA-2022-0023-V323
Major variation for application PMDA-2022-0023. Major variation: Manufacturing Process Change for Upadacitimab — minor update
Variation Number
PMDA-2022-0023-V323
Type
Major
Application
Change
Status
Active
Fee
€49,428
Submitted
2022-08-31
Approved
—
Description
Major variation: Manufacturing Process Change for Upadacitimab — minor update